-
1
-
-
0016746934
-
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. characterization of efector cells
-
Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. characterization of efector cells. Int J Cancer. 1975;16(2):230-239.
-
(1975)
Int J Cancer
, vol.16
, Issue.2
, pp. 230-239
-
-
Herberman, R.B.1
Nunn, M.E.2
Holden, H.T.3
Lavrin, D.H.4
-
2
-
-
0016711166
-
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. distribution of reactivity and specificity
-
Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. distribution of reactivity and specificity. Int J Cancer. 1975;16(2):216-229.
-
(1975)
Int J Cancer
, vol.16
, Issue.2
, pp. 216-229
-
-
Herberman, R.B.1
Nunn, M.E.2
Lavrin, D.H.3
-
3
-
-
42449102990
-
Up on the tightrope: Natural killer cell activation and inhibition
-
Lanier LL. Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol. 2008;9(5):495-502.
-
(2008)
Nat Immunol
, vol.9
, Issue.5
, pp. 495-502
-
-
Lanier, L.L.1
-
5
-
-
0022317963
-
Host resistance directed selectively against H-2-defcient lym-phoma variants. analysis of the mechanism
-
Ljunggren HG, Karre K. Host resistance directed selectively against H-2-defcient lym-phoma variants. analysis of the mechanism. J Exp Med. 1985;162(6):1745-1759.
-
(1985)
J Exp Med
, vol.162
, Issue.6
, pp. 1745-1759
-
-
Ljunggren, H.G.1
Karre, K.2
-
6
-
-
0023792164
-
Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
-
Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988;141(10):3478-3485.
-
(1988)
J Immunol
, vol.141
, Issue.10
, pp. 3478-3485
-
-
Lanier, L.L.1
Ruitenberg, J.J.2
Phillips, J.H.3
-
7
-
-
0030996297
-
Te receptor for the cytotoxic ligand TRAIL
-
Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. Te receptor for the cytotoxic ligand TRAIL. Science. 1997;276(5309):111-113.
-
(1997)
Science
, vol.276
, Issue.5309
, pp. 111-113
-
-
Pan, G.1
O'Rourke, K.2
Chinnaiyan, A.M.3
Gentz, R.4
Ebner, R.5
Ni, J.6
Dixit, V.M.7
-
8
-
-
33745567831
-
Self-tolerance of natural killer cells
-
Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6(7): 520-531.
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.7
, pp. 520-531
-
-
Raulet, D.H.1
Vance, R.E.2
-
9
-
-
78149439385
-
CD57 defnes a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
-
Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL. CD57 defnes a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010;116(19):3865-3874.
-
(2010)
Blood
, vol.116
, Issue.19
, pp. 3865-3874
-
-
Lopez-Verges, S.1
Milush, J.M.2
Pandey, S.3
York, V.A.4
Arakawa-Hoyt, J.5
Pircher, H.6
Norris, P.J.7
Nixon, D.F.8
Lanier, L.L.9
-
10
-
-
84868593211
-
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen
-
Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, anasetti C, Weisdorf D, Miller JS. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol. 2012;189(10):5082-5088.
-
(2012)
J Immunol
, vol.189
, Issue.10
, pp. 5082-5088
-
-
Foley, B.1
Cooley, S.2
Verneris, M.R.3
Curtsinger, J.4
Luo, X.5
Waller, E.K.6
Anasetti, C.7
Weisdorf, D.8
Miller, J.S.9
-
11
-
-
79951834889
-
NK cells and immune memory
-
Sun JC, Lopez-Verges S, Kim CC, DeRisi JL, Lanier LL. NK cells and immune "memory". J Immunol. 2011;186(4):1891-1897.
-
(2011)
J Immunol
, vol.186
, Issue.4
, pp. 1891-1897
-
-
Sun, J.C.1
Lopez-Verges, S.2
Kim, C.C.3
Derisi, J.L.4
Lanier, L.L.5
-
12
-
-
79951695881
-
Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
-
Sun JC, Beilke JN, Bezman NA, Lanier LL. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med. 2011;208(2):357-368.
-
(2011)
J Exp Med
, vol.208
, Issue.2
, pp. 357-368
-
-
Sun, J.C.1
Beilke, J.N.2
Bezman, N.A.3
Lanier, L.L.4
-
13
-
-
0023115642
-
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
-
Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987;316(15):889-897.
-
(1987)
N Engl J Med
, vol.316
, Issue.15
, pp. 889-897
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Muul, L.M.3
Chang, A.E.4
Avis, F.P.5
Leitman, S.6
Linehan, W.M.7
Robertson, C.N.8
Lee, R.E.9
Rubin, J.T.10
Seipp, C.A.11
Simpson, C.G.12
White, D.E.13
-
14
-
-
0037086131
-
Efectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
-
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Mertelli MF, Velardi A. Efectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100.
-
(2002)
Science
, vol.295
, Issue.5562
, pp. 2097-2100
-
-
Ruggeri, L.1
Capanni, M.2
Urbani, E.3
Perruccio, K.4
Shlomchik, W.D.5
Tosti, A.6
Posati, S.7
Rogaia, D.8
Frassoni, F.9
Aversa, F.10
Mertelli, M.F.11
Velardi, A.12
-
15
-
-
0033168770
-
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
-
Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, Urbani E, Negrin RS, Martelli MF, Velardi A. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94(1):333-339.
-
(1999)
Blood
, vol.94
, Issue.1
, pp. 333-339
-
-
Ruggeri, L.1
Capanni, M.2
Casucci, M.3
Volpi, I.4
Tosti, A.5
Perruccio, K.6
Urbani, E.7
Negrin, R.S.8
Martelli, M.F.9
Velardi, A.10
-
16
-
-
20144388509
-
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
-
Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8): 3051-3057.
-
(2005)
Blood
, vol.105
, Issue.8
, pp. 3051-3057
-
-
Miller, J.S.1
Soignier, Y.2
Panoskaltsis-Mortari, A.3
McNearney, S.A.4
Yun, G.H.5
Fautsch, S.K.6
McKenna, D.7
Le, C.8
Defor, T.E.9
Burns, L.J.10
Orchard, P.J.11
Blazar, B.R.12
Wagner, J.E.13
Slungaard, A.14
Weisdorf, D.J.15
Okazaki, I.J.16
McGlave, P.B.17
-
17
-
-
84881169028
-
Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 Bispecific killer cell engager and ADAM17 inhibition
-
Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 Bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19(14):3844-3855.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.14
, pp. 3844-3855
-
-
Wiernik, A.1
Foley, B.2
Zhang, B.3
Verneris, M.R.4
Warlick, E.5
Gleason, M.K.6
Ross, J.A.7
Luo, X.8
Weisdorf, D.J.9
Walcheck, B.10
Vallera, D.A.11
Miller, J.S.12
-
18
-
-
84871389574
-
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production
-
Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS. Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production. Mol Cancer Ter. 2012;11(12):2674-2684.
-
(2012)
Mol Cancer Ter
, vol.11
, Issue.12
, pp. 2674-2684
-
-
Gleason, M.K.1
Verneris, M.R.2
Todhunter, D.A.3
Zhang, B.4
McCullar, V.5
Zhou, S.X.6
Panoskaltsis-Mortari, A.7
Weiner, L.M.8
Vallera, D.A.9
Miller, J.S.10
-
19
-
-
84879703012
-
NK cell CD16 surface expression and function is regulated by a dis- integrin and metalloprotease-17 (ADAM17)
-
Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J. NK cell CD16 surface expression and function is regulated by a dis- integrin and metalloprotease-17 (ADAM17). Blood. 2013;121(18):3599-3608.
-
(2013)
Blood
, vol.121
, Issue.18
, pp. 3599-3608
-
-
Romee, R.1
Foley, B.2
Lenvik, T.3
Wang, Y.4
Zhang, B.5
Ankarlo, D.6
Luo, X.7
Cooley, S.8
Verneris, M.9
Walcheck, B.10
Miller, J.11
-
20
-
-
11144299492
-
NK cell recognition
-
Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 225-274
-
-
Lanier, L.L.1
-
21
-
-
4444243490
-
Killer immunoglob-ulin-like receptors
-
Moretta L, Moretta A. Killer immunoglob-ulin-like receptors. Curr Opin Immunol. 2004;16(5):626-633.
-
(2004)
Curr Opin Immunol
, vol.16
, Issue.5
, pp. 626-633
-
-
Moretta, L.1
Moretta, A.2
-
22
-
-
33845252269
-
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
-
Grzywacz B, Kataria N, Sikora M, Oostendorp RA, Dzierzak EA, Blazar BR, Miller JS, Verneris MR. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 2006;108(12):3824-3833.
-
(2006)
Blood
, vol.108
, Issue.12
, pp. 3824-3833
-
-
Grzywacz, B.1
Kataria, N.2
Sikora, M.3
Oostendorp, R.A.4
Dzierzak, E.A.5
Blazar, B.R.6
Miller, J.S.7
Verneris, M.R.8
-
23
-
-
34547667110
-
Diferentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis
-
Rohner A, Langenkamp U, Siegler U, Kalberer CP, Wodnar-Filipowicz A. Diferentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk Res. 2007;31(10):1393-1402.
-
(2007)
Leuk Res
, vol.31
, Issue.10
, pp. 1393-1402
-
-
Rohner, A.1
Langenkamp, U.2
Siegler, U.3
Kalberer, C.P.4
Wodnar-Filipowicz, A.5
-
24
-
-
20144385362
-
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112)
-
Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, Flaco M, Lanino E, Pierri I, Zambello R, Bacigalupo A, Mingari MC, Moretta A, Moretta L. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood. 2005;105(5):2066-2073.
-
(2005)
Blood
, vol.105
, Issue.5
, pp. 2066-2073
-
-
Pende, D.1
Spaggiari, G.M.2
Marcenaro, S.3
Martini, S.4
Rivera, P.5
Capobianco, A.6
Flaco, M.7
Lanino, E.8
Pierri, I.9
Zambello, R.10
Bacigalupo, A.11
Mingari, M.C.12
Moretta, A.13
Moretta, L.14
-
25
-
-
77951174364
-
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade
-
Godal R, Bachanova V, Gleason M, McCullar V, Yun GH, Cooley S, Verneris MR, McGlave PB, Miller JS. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade. Biol Blood Marrow Transplant. 2010;16(5):612-621.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, Issue.5
, pp. 612-621
-
-
Godal, R.1
Bachanova, V.2
Gleason, M.3
McCullar, V.4
Yun, G.H.5
Cooley, S.6
Verneris, M.R.7
McGlave, P.B.8
Miller, J.S.9
-
26
-
-
0032885461
-
Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu
-
Cooley S, Burns LJ, Repka T, Miller JS. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol. 1999;27(10):1533-1541.
-
(1999)
Exp Hematol
, vol.27
, Issue.10
, pp. 1533-1541
-
-
Cooley, S.1
Burns, L.J.2
Repka, T.3
Miller, J.S.4
-
27
-
-
33845995455
-
Recombinant interleukin-2 signifcantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma
-
Lopes de Menezes DE, Denis-Mize K, Tang Y, Ye H, Kunich JC, Garrett EN, Peng J, Cousens LS, Gelb AB, Heise C, Wilson SE, Jallal B, Aukerman SL. Recombinant interleukin-2 signifcantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma. J Immunother. 2007;30(1):64-74.
-
(2007)
J Immunother
, vol.30
, Issue.1
, pp. 64-74
-
-
De Lopes Menezes, D.E.1
Denis-Mize, K.2
Tang, Y.3
Ye, H.4
Kunich, J.C.5
Garrett, E.N.6
Peng, J.7
Cousens, L.S.8
Gelb, A.B.9
Heise, C.10
Wilson, S.E.11
Jallal, B.12
Aukerman, S.L.13
-
28
-
-
10744220588
-
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: A phase I/II trial
-
Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: A phase I/II trial. Bone Marrow Transplant. 2003;32(2):177-186.
-
(2003)
Bone Marrow Transplant
, vol.32
, Issue.2
, pp. 177-186
-
-
Burns, L.J.1
Weisdorf, D.J.2
Defor, T.E.3
Vesole, D.H.4
Repka, T.L.5
Blazar, B.R.6
Burger, S.R.7
Panoskaltsis-Mortari, A.8
Keever-Taylor, C.A.9
Zhang, M.J.10
Miller, J.S.11
-
29
-
-
33744521309
-
Missing self recognition and self tolerance of natural killer (NK) cells
-
Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol. 2006;18(3):145-150.
-
(2006)
Semin Immunol
, vol.18
, Issue.3
, pp. 145-150
-
-
Raulet, D.H.1
-
30
-
-
33750721289
-
Taking license with natural killer cell maturation and repertoire development
-
Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155-160.
-
(2006)
Immunol Rev
, vol.214
, pp. 155-160
-
-
Parham, P.1
-
31
-
-
77957747686
-
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
-
Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med. 2010;207(10):2065-2072.
-
(2010)
J Exp Med
, vol.207
, Issue.10
, pp. 2065-2072
-
-
Joncker, N.T.1
Shifrin, N.2
Delebecque, F.3
Raulet, D.H.4
-
32
-
-
0037086131
-
Efectiveness of donor natural killer cell alloreactivity in mismatched hematopoi-etic transplants
-
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A. Efectiveness of donor natural killer cell alloreactivity in mismatched hematopoi-etic transplants. Science. 2002;295(5562): 2097-2100.
-
(2002)
Science
, vol.295
, Issue.5562
, pp. 2097-2100
-
-
Ruggeri, L.1
Capanni, M.2
Urbani, E.3
Perruccio, K.4
Shlomchik, W.D.5
Tosti, A.6
Posati, S.7
Rogaia, D.8
Frassoni, F.9
Aversa, F.10
Martelli, M.F.11
Velardi, A.12
-
33
-
-
84862120656
-
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant
-
Velardi A, Ruggeri L, Mancusi A. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. Curr Opin Hematol. 2012;19(4):319-323.
-
(2012)
Curr Opin Hematol
, vol.19
, Issue.4
, pp. 319-323
-
-
Velardi, A.1
Ruggeri, L.2
Mancusi, A.3
-
34
-
-
77958040684
-
Allogeneic natural killer cells for refractory lymphoma
-
Bachanova V, Burns LJ, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lindgren BR, Cooley S, Weisdorf D, Miller JS. Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother. 2010;59(11):1739-1744.
-
(2010)
Cancer Immunol Immunother
, vol.59
, Issue.11
, pp. 1739-1744
-
-
Bachanova, V.1
Burns, L.J.2
McKenna, D.H.3
Curtsinger, J.4
Panoskaltsis-Mortari, A.5
Lindgren, B.R.6
Cooley, S.7
Weisdorf, D.8
Miller, J.S.9
-
35
-
-
78650400901
-
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
-
Geller MA, Cooley S, Judson PL, Ghebre R, Carson LF, Argenta PA, Jonson AL, Panoskaltsis-Mortari A, Curtsinger J, McKenna D, Dusenbery K, Bliss R, Downs LS, Miller JS. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy. 2011;13(1):98-107.
-
(2011)
Cytotherapy
, vol.13
, Issue.1
, pp. 98-107
-
-
Geller, M.A.1
Cooley, S.2
Judson, P.L.3
Ghebre, R.4
Carson, L.F.5
Argenta, P.A.6
Jonson, A.L.7
Panoskaltsis-Mortari, A.8
Curtsinger, J.9
McKenna, D.10
Dusenbery, K.11
Bliss, R.12
Downs, L.S.13
Miller, J.S.14
-
36
-
-
34147129582
-
Regulatory T cells inhibit fas ligand-induced innate and adaptive tumour immunity
-
Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Regulatory T cells inhibit fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol. 2007;37(3):758-767.
-
(2007)
Eur J Immunol
, vol.37
, Issue.3
, pp. 758-767
-
-
Simon, A.K.1
Jones, E.2
Richards, H.3
Wright, K.4
Betts, G.5
Godkin, A.6
Screaton, G.7
Gallimore, A.8
-
37
-
-
84880273084
-
Shedding of endogenous MHC class I-related chain molecules A and B from diferent human tumor entities: Heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17
-
Chitadze G, Lettau M, Bhat J, Wesch D, Steinle A, Fürst D, Mytilineos J, Kalthof H, Janssen O, Oberg HH, Kabelitz D. Shedding of endogenous MHC class I-related chain molecules A and B from diferent human tumor entities: Heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17. Int J Cancer. 2013;133(7):1557-1566.
-
(2013)
Int J Cancer
, vol.133
, Issue.7
, pp. 1557-1566
-
-
Chitadze, G.1
Lettau, M.2
Bhat, J.3
Wesch, D.4
Steinle, A.5
Fürst, D.6
Mytilineos, J.7
Kalthof, H.8
Janssen, O.9
Oberg, H.H.10
Kabelitz, D.11
-
38
-
-
84899660570
-
Optimal xenogeneic adoptive transfer of human NK cells: Fresh NK cells and IL-15 administration are superior to frozen NK cells and IL-2
-
Tolar J, Curtsinger J, McElmurry R, McCullar V, Verneris MR, van Rhee F, Lapteva N, Rooney CM, Wagner JE, Blazar BR, Miller JS., Optimal xenogeneic adoptive transfer of human NK cells: Fresh NK cells and IL-15 administration are superior to frozen NK cells and IL-2. ASH Annual Meeting Abstracts. 2012;120(21):346.
-
(2012)
ASH Annual Meeting Abstracts
, vol.120
, Issue.21
, pp. 346
-
-
Tolar, J.1
Curtsinger, J.2
McElmurry, R.3
McCullar, V.4
Verneris, M.R.5
van Rhee, F.6
Lapteva, N.7
Rooney, C.M.8
Wagner, J.E.9
Blazar, B.R.10
Miller, J.S.11
-
39
-
-
70449496690
-
Toward clinical therapies using hematopoietic cells derived from human plurip-otent stem cells
-
Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human plurip-otent stem cells. Blood. 2009;114(17):3513-3523.
-
(2009)
Blood
, vol.114
, Issue.17
, pp. 3513-3523
-
-
Kaufman, D.S.1
-
40
-
-
77957734984
-
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
-
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD, Ladner M, Trachtenberg E, Parham P, Miller JS. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
-
(2010)
Blood
, vol.116
, Issue.14
, pp. 2411-2419
-
-
Cooley, S.1
Weisdorf, D.J.2
Guethlein, L.A.3
Klein, J.P.4
Wang, T.5
Le, C.T.6
Marsh, S.G.7
Geraghty, D.8
Spellman, S.9
Haagenson, M.D.10
Ladner, M.11
Trachtenberg, E.12
Parham, P.13
Miller, J.S.14
|